Cart
sales@molnova.com
Dextran sulfate sodium salt (MW 16000-24000)
CAS No. 9011-18-1
Dextran sulfate sodium salt (MW 16000-24000)( —— )
Catalog No. M22832 CAS No. 9011-18-1
Dextran sulfate sodium salt (MW 16000-24000) is an anhydrous glucose polymer with a molecular weight range of 16000-24000. The sodium salt inhibits the replication of the human immunodeficiency virus by preventing the virus from absorbing the host cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 35 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDextran sulfate sodium salt (MW 16000-24000)
-
NoteResearch use only, not for human use.
-
Brief DescriptionDextran sulfate sodium salt (MW 16000-24000) is an anhydrous glucose polymer with a molecular weight range of 16000-24000. The sodium salt inhibits the replication of the human immunodeficiency virus by preventing the virus from absorbing the host cells.
-
DescriptionDextran sulfate sodium salt (MW 16000-24000) is an anhydrous glucose polymer with a molecular weight range of 16000-24000. The sodium salt inhibits the replication of the human immunodeficiency virus by preventing the virus from absorbing the host cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV|Apoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number9011-18-1
-
Formula Weight16000-24000
-
Molecular Formula——
-
Purity>98% (HPLC)
-
SolubilityNA
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Baba M, et al. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc Natl Acad Sci U S A. 1988 Aug;85(16):6132-6.
molnova catalog
related products
-
BMS-488043
BMS-488043 is a novel and unique oral small molecule HIV fusion inhibitor that inhibits the attachment of Human Immunodeficiency Virus type 1 (HIV-1) to CD4(+) lymphocytes.
-
Diphyllin
Diphyllin could be characterized as a new V-ATPase inhibitor in treating gastric cancer and inhibiting the phosphorylation of LRP6 in Wnt/β-catenin signaling.
-
I-XW-053
I-XW-053 is an inhibitor of capsid targeted HIV-1 replication using the hybrid structure based method to block the interface between CA N-terminal domains (NTD-NTD interface) with micromolar affinity.
